Active ingredientFlibanserinCat. No. P-F058-001CAS 167933-07-5Family · Pharmaceutical analytical standards
Flibanserin
A drug acting on serotonin receptors (5-HT1A agonist and 5-HT2A antagonist), approved in the United States in 2015 for premenopausal women with acquired hypoactive sexual desire disorder. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was first developed as an antidepressant: during the studies its effects on sexual desire emerged and it was repurposed, becoming the first FDA-approved treatment for this female disorder.
Go to the active ingredient →Active ingredientFlibanserinCat. No. P-F058-001CAS 167933-07-5
Active ingredientFlibanserin HClCat. No. P-F058-002CAS 147359-76-0
Isotopically labelledFlibanserin-d4Cat. No. P-F058-003CAS 2122830-91-3
ImpurityFlibanserin Impurity 1Cat. No. P-F058-004CAS 14678-81-0
ImpurityFlibanserin Impurity 2Cat. No. P-F058-005CAS 60568-46-9
ImpurityFlibanserin Impurity 3Cat. No. P-F058-006CAS 6276-48-8
ImpurityFlibanserin Impurity 4Cat. No. P-F058-007
ImpurityFlibanserin Impurity 5Cat. No. P-F058-008
ImpurityFlibanserin Impurity 6Cat. No. P-F058-009
ImpurityFlibanserin Impurity 7Cat. No. P-F058-010
ImpurityFlibanserin Impurity 8Cat. No. P-F058-011
ImpurityFlibanserin Impurity 9Cat. No. P-F058-012
ImpurityFlibanserin Impurity 10Cat. No. P-F058-013No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.